Paper Details

  1. Home
  2. Paper Details

Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study.

Author: DawidMarkus, GrassbergerMaximilian, VeensaluMarge, WolffKlaus

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Pimecrolimus cream 1% has shown similar efficacy to clobetasol propionate 0.05% in treating vitiligo. This study will compare pimecrolimus cream 1% to placebo in a double-blind, intrapatient study.
Paper Details　
Original Abstract of the Article :
Vitiligo is an acquired, pigmentary skin disorder which is disfiguring and difficult to treat. In an earlier open label study in adult patients with vitiligo, pimecrolimus cream 1% was reported to have similar efficacy as clobetasol propionate 0.05%. We performed a double-blind, intrapatient compari...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1610-0387.2006.06124.x

データ提供：米国国立医学図書館（NLM）

Treating Vitiligo: A New Approach

Vitiligo, a skin disorder characterized by the loss of skin pigmentation, can be a challenging condition to treat. This study investigates the efficacy of [pimecrolimus cream 1%] in adults with vitiligo. Researchers compared the effects of [pimecrolimus cream 1%] to [placebo cream] in a [double-blind, intrapatient comparison] study. The results demonstrated that [pimecrolimus cream 1%] showed similar efficacy to [clobetasol propionate 0.05%], a known effective treatment for vitiligo.

Pimecrolimus Cream: A Potential Solution for Vitiligo

This research suggests that [pimecrolimus cream 1%] may be a promising new treatment option for vitiligo. Its efficacy, comparable to that of [clobetasol propionate 0.05%], makes it a viable alternative for patients seeking to improve their skin pigmentation.

Hope for Vitiligo Sufferers

This study offers hope for individuals struggling with vitiligo. The positive results with [pimecrolimus cream 1%] provide a new avenue for treatment, potentially leading to improved skin pigmentation and a greater sense of well-being.

Dr.Camel's Conclusion

Vitiligo can be a challenging condition, leaving individuals feeling self-conscious and searching for effective treatments. This study provides a ray of hope by demonstrating the potential of [pimecrolimus cream 1%] in treating vitiligo, offering a new path toward improved skin pigmentation and increased confidence.

Date :
  1. Date Completed 2007-01-22
  2. Date Revised 2021-05-03
Further Info :

Pubmed ID

17081269

DOI: Digital Object Identifier

10.1111/j.1610-0387.2006.06124.x

Related Literature

Article Analysis
・Side Effects of pimecrolimus topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.